Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-05-06

Clinical Trial Update: PraevoSkin Emulsion in the Prevention of Radiation Induced Dermatitis

View source ↗

Summary

An update on a clinical trial evaluating PraevoSkin Emulsion to prevent radiation-induced dermatitis; no results or status details are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PraevoSkin Emulsion

Snippet

Sponsor: Pharm Olam Pharmaceuticals Ltd. | Conditions: Prevention of Radiation Induced Dermatitis. | Status: UNKNOWN